Badgley Phelps Wealth Managers’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$308K Sell
7,207
-103,928
-94% -$5.64M 0.01% 284
2026
Q1
$6.97M Buy
111,135
+1,423
+1% +$114K 0.14% 120
2025
Q4
$10.5M Buy
109,712
+3,006
+3% +$295K 0.19% 113
2025
Q3
$10.4M Buy
106,706
+1,758
+2% +$182K 0.22% 104
2025
Q2
$11.3M Buy
104,948
+2,376
+2% +$240K 0.25% 99
2025
Q1
$10.3M Buy
102,572
+5,068
+5% +$510K 0.25% 106
2024
Q4
$8.71M Buy
97,504
+9,161
+10% +$806K 0.2% 108
2024
Q3
$7.4M Buy
88,343
+12,701
+17% +$1M 0.17% 113
2024
Q2
$5.83M Buy
+75,642
New +$5.54M 0.14% 115

Other funds holding BSX

Badgley Phelps Wealth Managers's BSX Position: Q2 2026 in Review

Badgley Phelps Wealth Managers reduced its Boston Scientific (BSX) stake by 94% in Q2 2026, selling an estimated $5.64M and leaving 7,207 shares worth $308K. The position accounts for 0.01% of the portfolio, ranked #284.

Badgley Phelps Wealth Managers first reported a position in BSX in Q2 2024 and has held it in 9 quarters since. The position peaked at $11.3M in Q2 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Badgley Phelps Wealth Managers held 7,207 shares of Boston Scientific worth $308K as of Q2 2026.
  • Badgley Phelps Wealth Managers sold 103,928 Boston Scientific shares in Q2 2026, an estimated $5.64M.
  • Boston Scientific made up 0.01% of Badgley Phelps Wealth Managers's portfolio in Q2 2026, its #284 holding.
  • Badgley Phelps Wealth Managers first reported a position in Boston Scientific in Q2 2024 and has held it in 9 quarters since.
  • Badgley Phelps Wealth Managers's Boston Scientific position peaked at $11.3M in Q2 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Badgley Phelps Wealth Managers's 13F filing for Q2 2026, filed 31 Jul 2026.